HTG Molecular Diagnostics, Inc. Current Foreign Tax Expense (Benefit)
HTG Molecular Diagnostics, Inc. reported Current Foreign Tax Expense (Benefit) of $7.57 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Expense Statement › Income Tax
us-gaap:CurrentForeignTaxExpenseBenefit · last filed 2023-03-30
- HTG Molecular Diagnostics, Inc. current foreign tax expense (benefit) for fiscal 2022 was $7.57K, a 13.08% decline from fiscal 2021.
- HTG Molecular Diagnostics, Inc. current foreign tax expense (benefit) for fiscal 2021 was $8.71K, a 144.89% increase from fiscal 2020.
- HTG Molecular Diagnostics, Inc. current foreign tax expense (benefit) for fiscal 2020 was $3.56K.
| Period end | Current Foreign Tax Expense (Benefit) 12 month |
|---|---|
| 2022-12-31 | $7.57K 10-K · filed 2023-03-30 |
| 2021-12-31 | $8.71K 10-K · filed 2023-03-30 |
| 2020-12-31 | $3.56K 10-K · filed 2022-03-29 |